发明名称 |
BIOMARKERS FOR CERVICAL CANCER |
摘要 |
The present invention relates to biomarkers for chemoradioresistant subtypes of cervical cancer. In particular the present invention relates to a method for predicting a predisposition to a chemoradioresistant cervical cancer in a subject, a method for diagnosing a chemoradioresistant cervical cancer in a subject, a method for predicting the likelihood of recurrence of cervical cancer in a cervical cancer patient under treatment, and a method for predicting the prognosis for a patient with a chemoradioresistant cervical cancer. |
申请公布号 |
US2016046997(A1) |
申请公布日期 |
2016.02.18 |
申请号 |
US201314436680 |
申请日期 |
2013.10.17 |
申请人 |
Oslo universitetssykehus HF |
发明人 |
Lyng Heidi;Lando Malin |
分类号 |
C12Q1/68;G01N33/574 |
主分类号 |
C12Q1/68 |
代理机构 |
|
代理人 |
|
主权项 |
1. A kit for detecting loss of gene expression associated with cervical cancer, consisting essentially of:
a) a first gene expression informative reagent for identification of loss or decrease of gene expression of a first gene located at the chromosomal region 3p11.2-p14.2; and b) a second gene expression informative reagent for identification of loss or decrease of gene expression of a second gene located at the chromosomal region 3p11.2-p14.2. |
地址 |
Oslo NO |